Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
jingang wan
- Development stage
- Unknown
- Lead developer
- Shaanxi Tianyang Pharmaceutical
- Administration
- Oral
01
Overview
Jingang Wan is a traditional Chinese medicine (TCM) formulation manufactured by Shaanxi Tianyang Pharmaceutical. It is primarily indicated for the treatment of rheumatism and conditions associated with kidney deficiency, such as weakness in the lower back and knees, and difficulty walking. The preparation typically consists of a blend of herbal ingredients, including Cistanche deserticola, Eucommia ulmoides, and Morinda officinalis, which are traditionally used in TCM to tonify the liver and kidneys and strengthen tendons and bones. It is an approved pharmaceutical product in China, often used to address chronic musculoskeletal pain and weakness.
- Brand names
- Jingang Wan
- Other names
- 金刚丸
Beyond the preview
Go deeper on jingang wan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on jingang wan.